Sulfamoyl substituted phenethylamine intermediates

Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

564 85, 564 86, C07C31116

Patent

active

053918258

ABSTRACT:
Pharmaceutical compositions are provided for the treatment of disorders in a subject, such as hypertension, congestive heart failure, angina pectoris, lower urinary tract dysfunction and prostatic hypertrophy. The compositions when administered to a subject produce an .alpha.-adrenergic blocking action and contain as an active ingredient sulfamoyl-substituted phenethylamine derivatives, such as optically active 5-2-[2-(2-ethoxyphenoxy)ethylamino]-2-methylethyl-2-methoxybenzenesulfonam ide, and a pharmaceutically acceptable carrier.

REFERENCES:
patent: 3860647 (1975-01-01), Colella et al.
patent: 4140713 (1979-02-01), Oxford et al.
patent: 4217305 (1980-08-01), Imai et al.
patent: 4703063 (1987-10-01), Imai et al.
patent: 4868216 (1989-09-01), Imai et al.
patent: 4971990 (1990-11-01), Itoh et al.
patent: 4987152 (1991-01-01), Imai et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Sulfamoyl substituted phenethylamine intermediates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfamoyl substituted phenethylamine intermediates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfamoyl substituted phenethylamine intermediates will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1931928

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.